Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

A new compound effectively inhibits human 5α-reductase 1.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

New psoriasis treatments are effective but come with side effects and risks.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Intralesional steroid therapy is useful for treating various skin conditions.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Oral tetracycline reduces fat breakdown in hair lipids.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Testosterone in our bodies helps increase insulin secretion from the pancreas.

Valproic acid and isoniazid can interact, causing toxicity, so careful monitoring is needed.